Compare · NEOV vs TMO
NEOV vs TMO
Side-by-side comparison of NeoVolta Inc. (NEOV) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- NEOV operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO carries a market cap of $225.41B.
- Over the past year, NEOV is up 4.1% and TMO is up 11.5% - TMO leads by 7.3 points.
- TMO has been more active in the news (6 items in the past 4 weeks vs 2 for NEOV).
- TMO has more recent analyst coverage (25 ratings vs 2 for NEOV).
- Company
- NeoVolta Inc.
- Thermo Fisher Scientific Inc
- Price
- $2.79-0.54%
- $469.57+0.63%
- Market cap
- -
- $225.41B
- 1M return
- -31.74%
- -4.31%
- 1Y return
- +4.11%
- +11.45%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 2
- 6
- Recent ratings
- 2
- 25
NeoVolta Inc.
NeoVolta Inc. designs, manufactures, and sells energy storage systems in the United States. It offers NV14 and NV 24 energy storage systems to store and use energy through batteries and an inverter at residential or commercial sites. The company markets and sells its products directly to certified solar installers and solar equipment distributors. NeoVolta Inc. was founded in 2018 and is headquartered in Poway, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest NEOV
- NeoVolta Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- NeoVolta Increases Ownership of NeoVolta Power to 80% and Expands Strategic Commercial Capabilities
- NeoVolta Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits
- SEC Form 424B5 filed by NeoVolta Inc.
- NeoVolta Receives $1.9 Million First Purchase Order from Luminia, Accelerating Commercial and Industrial Energy Storage Platform
- SEC Form 4 filed by Ibrahim Amany
- SEC Form 4 filed by Enzendorfer Thomas
- SEC Form 4 filed by Chief Financial Officer Bond Steve
- SEC Form 4 filed by CEO & President Johnson Henry Ardes
- NeoVolta Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026
- SEC Form 4 filed by Sperling Scott M
- SEC Form 4 filed by Keith R. Alexandra
- SEC Form 4 filed by Lynch Karen S